RTI International, 351 California St, Suite 500, San Francisco, CA, 94104, USA.
University of California, San Francisco, San Francisco, CA, USA.
Addict Sci Clin Pract. 2017 Jun 14;12(1):13. doi: 10.1186/s13722-017-0078-9.
People who smoke crack cocaine and people who inject drugs are at-risk for criminal justice involvement as well as HIV and HCV infection. Compared to criminal justice involvement, substance use treatment (SUT) can be cost-effective in reducing drug use and its associated health and social costs. We conducted a cross-sectional study of people who smoke crack cocaine and people who inject drugs to examine the association between incarceration, community supervision and substance use treatment with HIV/HCV testing, components of the HIV treatment cascade, social and physical vulnerability and risk behavior.
Targeted sampling methods were used to recruit people who smoke crack cocaine and people who inject drugs (N = 2072) in Oakland, California from 2011 to 2013. Poisson regression models were used to estimate adjusted prevalence ratios between study exposures and outcomes.
The overall HIV prevalence was 3.3% (95% CI 2.6-4.1). People previously experiencing incarceration were 21% (p < 0.001) and 32% (p = 0.001), respectively, more likely to report HIV and HCV testing; and were not more likely to report receiving HIV care or initiating ART. People previously experiencing community supervision were 17% (p = 0.001) and 15% (p = 0.009), respectively, more likely to report HIV and HCV testing; and were not more likely to report receiving HIV care or initiating ART. People with a history of SUT were 15% (p < 0.001) and 23% (p < 0.001), respectively, more likely to report receiving HIV and HCV testing, 67% (p = 0.016) more likely to report HIV care, and 92% (p = 0.012) more likely to report HIV treatment initiation. People previously experiencing incarceration or community supervision were also more likely to report homelessness, trouble meeting basic needs and risk behavior.
People with a history of substance use treatment reported higher levels of HCV and HIV testing and greater access to HIV care and treatment among HIV-positive individuals. People with a history of incarceration or community supervision reported higher levels of HCV and HIV testing, but not greater access to HIV care or treatment among HIV-positive individuals., Substance use treatment programs that are integrated with other services for HIV and HCV will be critical to simultaneously address the underlying reasons drug-involved people engage in drug-related offenses and improve access to essential medical services.
吸食快克可卡因的人和注射毒品的人都面临着刑事司法介入以及感染 HIV 和 HCV 的风险。与刑事司法介入相比,药物使用治疗 (SUT) 可以通过减少药物使用及其相关的健康和社会成本而具有成本效益。我们对吸食快克可卡因的人和注射毒品的人进行了一项横断面研究,以检查监禁、社区监督和药物使用治疗与 HIV/HCV 检测、HIV 治疗级联的组成部分、社会和身体脆弱性以及风险行为之间的关联。
2011 年至 2013 年,我们在加利福尼亚州奥克兰采用靶向抽样方法招募吸食快克可卡因的人和注射毒品的人(N=2072)。我们使用泊松回归模型估计研究暴露与结果之间的调整后患病率比。
总体 HIV 患病率为 3.3%(95%CI 2.6-4.1)。以前经历过监禁的人分别有 21%(p<0.001)和 32%(p=0.001)更有可能报告 HIV 和 HCV 检测;并且不太可能报告接受 HIV 护理或开始 ART。以前经历过社区监督的人分别有 17%(p=0.001)和 15%(p=0.009)更有可能报告 HIV 和 HCV 检测;并且不太可能报告接受 HIV 护理或开始 ART。有 SUT 治疗史的人分别有 15%(p<0.001)和 23%(p<0.001)更有可能报告接受 HIV 和 HCV 检测,67%(p=0.016)更有可能报告 HIV 护理,92%(p=0.012)更有可能报告 HIV 治疗开始。以前经历过监禁或社区监督的人也更有可能报告无家可归、难以满足基本需求和风险行为。
有药物使用治疗史的人报告 HCV 和 HIV 检测水平更高,并且在 HIV 阳性个体中获得 HIV 护理和治疗的机会更多。有监禁或社区监督史的人报告 HCV 和 HIV 检测水平更高,但在 HIV 阳性个体中获得 HIV 护理和治疗的机会没有更多。将药物使用治疗计划与 HIV 和 HCV 的其他服务相结合,对于同时解决吸毒者从事与毒品有关的犯罪的根本原因以及改善获得基本医疗服务的机会至关重要。